Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors
Source abstract
Abstract
To provide site-specific delivery and targeted release of growth factors to implanted urine-derived stem cells (USCs), we prepared microbeads of alginate containing growth factors. The growth factors included VEGF, IGF-1, FGF-1, PDGF, HGF and NGF. Radiolabeled growth factors were loaded separately and used to access the in vitro release from the microbeads with a gamma counter over 4 weeks. In vitro endothelial differentiation of USCs by the released VEGF from the microbeads in a separate experiment confirmed that the released growth factors from the microbeads were bioactive. USCs and microbeads were mixed with the collagen gel type 1 (2 mg/ml) and used for in vivo studies through subcutaneous injection into nude mice. Four weeks after subcutaneous injection, we found that grafted cell survival was improved and more cells expressed myogenic and endothelial cell transcripts and markers compared to controls. More vessel formation and innervations were observed in USCs combined with six growth factors cocktail incorporated in microbeads compared to controls. In conclusion, a combination of growth factors released locally from the alginate microbeads induced USCs to differentiate into a myogenic lineage, enhanced revascularization and innervation, and stimulated resident cell growth in vivo. This approach could potentially be used for cell therapy in the treatment of stress urinary incontinence.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Urological Disorders and Treatments · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Effect of pelvic muscle exercise on transient incontinence during pregnancy and after birth10.1016/S0029-7844(97)00672-8 ↗
2. Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey
3. Annual direct cost of urinary incontinence
4. Medical management of stress urinary incontinence: is there a future?10.1007/s11934-009-0063-2 ↗
5. Surgical treatment for stress and urge urinary incontinence10.1016/j.ogc.2009.08.009 ↗
6. Urethral bulking agents: techniques and outcomes10.1007/s11934-009-0062-3 ↗
7. Myoblasts and fibroblasts in stress urinary incontinence10.1016/S0140-6736(07)60990-8 ↗
8. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence10.1016/j.urology.2007.01.050 ↗
9. Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux
10. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup
11. Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence
12. Complications of teflon injection for stress urinary incontinence10.1002/nau.1930120206 ↗
13. Periurethral abscess following polyacrylamide hydrogel (Bulkamid(R)) for stress urinary incontinence10.1007/s00192-012-1768-1 ↗
14. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection10.1016/j.urology.2010.10.010 ↗
15. Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients
16. Stem cell therapy for stress urinary incontinence: a critical review10.1089/scd.2011.0621 ↗
17. Treatment of stress urinary incontinence with adipose tissue-derived stem cells10.3109/14653240903350265 ↗
18. Cellular therapy and urinary incontinence10.1016/j.purol.2012.04.008 ↗
19. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering10.1089/ten.tea.2010.0637 ↗
20. Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion10.1016/j.biomaterials.2010.07.108 ↗
21. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering10.1016/j.biomaterials.2010.10.006 ↗
22. Promoting muscle and nerve regeneration after human urine-derived stem cells expression of vascular endothelial growth factor for potential use in treatment of stress urinary incontinency
23. Sustained release of nerve growth factor from biodegradable polymer microspheres10.1227/00006123-199203000-00001 ↗
24. Bioartificial pancreas: evaluation of crucial barriers to clinical application
25. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration10.1016/j.mvr.2009.06.006 ↗
26. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization10.1016/j.jss.2009.06.003 ↗
27. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering10.1016/j.biomaterials.2009.12.053 ↗
28. In vivo skeletal myogenic differentiation of autologous urine-derived stem cells for potential application in treatment of urinary incontinence
29. Liu · 2012
30. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential10.1111/j.1432-0436.2008.00302.x ↗
31. Skeletal muscle differentiation of human urine-derived stem cells for injection therapy in the treatment of stress urinary incontinence
32. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging10.1016/j.ejcts.2006.03.043 ↗
33. Stem cells in tissue engineering10.1038/35102181 ↗
34. Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair10.1089/ten.tea.2010.0331 ↗
35. Cellular therapy for treatment of stress urinary incontinence10.2174/157488810790442840 ↗
36. Stem cells for regeneration of urological structures10.1016/j.eururo.2007.01.029 ↗
37. Adult stem cell therapy of female stress urinary incontinence10.1016/j.eururo.2007.07.026 ↗
38. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases10.1038/nrrheum.2009.104 ↗
39. Stem cell therapy for human neurodegenerative disorders-how to make it work10.1038/nm1064 ↗
40. Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model10.1016/j.jtcvs.2011.07.002 ↗
41. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects10.1161/01.CIR.104.1.115 ↗
42. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis10.1172/JCI18420 ↗
43. VEGF gene delivery to myocardium: deleterious effects of unregulated expression10.1161/01.CIR.102.8.898 ↗
44. Toward delivery of multiple growth factors in tissue engineering10.1016/j.biomaterials.2010.04.053 ↗
45. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments10.1098/rsif.2010.0223 ↗
46. Nanostructure-mediated drug delivery10.1016/j.nano.2004.11.009 ↗
47. Polymeric system for dual growth factor delivery10.1038/nbt1101-1029 ↗
48. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-110.1002/jbm.a.32883 ↗
49. Effects of VEGF temporal and spatial presentation on angiogenesis10.1016/j.biomaterials.2009.10.052 ↗
50. Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway10.1016/j.biomaterials.2012.07.041 ↗
51. Structural and functional studies on platelet-derived growth factor10.1002/j.1460-2075.1992.tb05523.x ↗
52. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration10.1096/fj.02-0183fje ↗